[ Price : $8.95]
FDA maintains a clinical hold on an Insmed Phase 3clinical trial for Arikace (liposomal amikacin for inhalation) in cystic fibrosi...[ Price : $8.95]
FDA clears a Cardium Therapeutics 510(k) for the Excellagen professional-use, sterile, syringe-based advanced wound care product f...[ Price : $8.95]
FDA approves an MSD International GmbH Clonmel NDA for Juvisync (sitagliptin and simvastatin), a fixed-dose convenience combinatio...[ Price : $8.95]
FDA and the Centers for Medicare & Medicaid Services (CMS) launch a parallel review two-year pilot program for approving medical d...[ Price : $8.95]
Federal Register Notice: FDA corrects an expiration date in a 9/12 Federal Register notice on OMB approval of an information colle...[ Price : $8.95]
Federal Register Notice: FDAs Antiviral Drugs Advisory Committee will meet 12/14-15 to discuss developing drug to treat smallpox i...[ Price : $8.95]
Federal Register Notice: FDA plans a public workshop 11/10 to discuss the science of abuse liability assessment.[ Price : $8.95]
FDA says AlloSource needs to submit a BLA for its AlloStem cell-scaffold product, which is intended to be used as a bone graft.